TOO CUTE KITTY!
"Last week, Kintor Pharmaceuticals announced the results of a randomized controlled trial of the use of anti-androgen proxalutamide, a prostate cancer drug, in mild to moderate COVID patients."
Horowitz: Another suppressed COVID treatment you haven’t heard of
The Blaze ^ | April 11, 2022 | Daniel HorowitzPosted on 4/11/2022, 1:33:04 PM by Twotone